AI-driven drug discovery firm Isomorphic Labs secured a massive $2.1 billion in Series B funding. This capital will fuel the expansion of t...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

A groundbreaking study published in Nature Medicine reveals that the experimental drug Elraglusib, when combined with standard chemotherapy...

Quote of the Day: Carl Rogers, a pioneer in psychology, believed true education is about learning to learn and change. His influential quot...

Biocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Ther...

Cannabis decision by the Federal Government Iargely legitimizes medical marijuana programs in the 40 states that have adopted them.

In India, appetite for weight-loss drugs is on the rise, with consumers increasingly turning to injectables such as Mounjaro and Ozempic fo...

The US blockade of the Strait of Hormuz, a claim by President Trump that negotiations are not dead in the water, and some tough talk from I...

Ankita Wamburkar’s struggle with unexplained health issues—initially misdiagnosed—highlights a wider gap in menopause awareness. Her eventu...

The new deal builds on existing collaborations between the two companies, which struck a software licensing agreement in 2023, according to...

The contract research organisations in the country have sought more clarity from the drug regulator on the process of filming clinical tria...

The clinical research division at Fortis Healthcare, also plans to hire more medical professionals next year.

The country’s drug regulator has suspended clinical research firm Axis Clinicals' permission to conduct all bio-availability and bio-equiva...

IT firm HCL Technologies on Monday made an entry into the Australian life sciences market by signing a deal with clinical research organisa...

The government will soon make it mandatory for all firms involved in clinical research to maintain minimum quality standards and register t...

The government has begun speeding up approvals in the area of clinical research which is set to boom in India.

Small and mid-size pharma companies focused on outsourcing seem to have caught the attention of investors, if the recent investments by pri...